Cargando…

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance

INTRODUCTION: The cancer stem cell (CSC) hypothesis states that tumours consist of a cellular hierarchy with CSCs at the apex driving tumour recurrence and metastasis. Hence, CSCs are potentially of profound clinical importance. We set out to establish the clinical relevance of breast CSC markers by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, H Raza, Dawson, Sarah-Jane, Blows, Fiona M, Provenzano, Elena, Pharoah, Paul D, Caldas, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326560/ https://www.ncbi.nlm.nih.gov/pubmed/22112299 http://dx.doi.org/10.1186/bcr3061

Ejemplares similares

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2014)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays
por: Blows, Fiona M., et al.
Publicado: (2016)

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer
por: Ali, A M G, et al.
Publicado: (2011)

Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
por: Mavaddat, Nasim, et al.
Publicado: (2010)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2019)

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
por: Callagy, Grace M, et al.
Publicado: (2008)

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer
por: Ali, H R, et al.
Publicado: (2013)

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape
por: Modelska, A, et al.
Publicado: (2015)

Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers
por: Bane, Anita, et al.
Publicado: (2013)

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
por: Ali, H. Raza, et al.
Publicado: (2016)

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
por: Ali, H. Raza, et al.
Publicado: (2016)

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
por: Taneja, Pankaj, et al.
Publicado: (2010)

Multi-omic machine learning predictor of breast cancer therapy response
por: Sammut, Stephen-John, et al.
Publicado: (2021)

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer
por: Sokolov, M, et al.
Publicado: (2015)

Prognostic significance of preoperative serum inflammation markers in patients with male breast cancer
por: Li, Xing, et al.
Publicado: (2021)

Prognostic and predictive value of PDL1 expression in breast cancer
por: Sabatier, Renaud, et al.
Publicado: (2014)

Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
por: KAWAJIRI, HIDEMI, et al.
Publicado: (2014)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Clinical prognostic significance of cancer stem cell markers in patients with papillary thyroid carcinoma
por: Ryu, Yoon-Jong, et al.
Publicado: (2020)

Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer
por: Ihemelandu, Chukwuemeka, et al.
Publicado: (2019)

Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker
por: Chong, Yosep, et al.
Publicado: (2020)

Prognostic gene network modules in breast cancer hold promise
por: Teschendorff, Andrew E, et al.
Publicado: (2010)

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
por: Chollet, P, et al.
Publicado: (2002)

Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2017)

Prognostic significance of serum inflammatory markers in esophageal cancer
por: Powell, Arfon G. M. T., et al.
Publicado: (2020)

Prognostic significance of immunoscore related markers in bladder cancer
por: Ariafar, Ali, et al.
Publicado: (2022)

Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
por: Prabhu, Kirti S., et al.
Publicado: (2020)

Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer
por: Mangogna, Alessandro, et al.
Publicado: (2018)

The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value
por: Zacchi, Paola, et al.
Publicado: (2021)

Pathological significance and prognostic role of LATS2 in prostate cancer
por: Matsuda, Tsuyoshi, et al.
Publicado: (2021)

Expression and prognostic significance of lysozyme in male breast cancer
por: Serra, Carlos, et al.
Publicado: (2002)

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
por: Pharoah, P D P, et al.
Publicado: (1999)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
por: Correia, Lizelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aujujlc6q27unsapdir0h9oqir